Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 110Sarcoma 58Lymphoid 9Gynecologic 3Genitourinary 3Gastrointestinal 2Dermatologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Head & Neck 1Endocrine 1Classical hematology 1Breast 1

Conditions

Melanoma 75Neoplasm Metastasis 9Brain Neoplasms 9Uveal Melanoma 7Skin Neoplasms 5Breast Neoplasms 4Glioblastoma 2Central Nervous System Neoplasms 2Zollinger-Ellison Syndrome 1Vipoma 1Somatostatinoma 1Sezary Syndrome 1Recurrence 1Prostatic Neoplasms 1Pheochromocytoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Neoplasms 1Mycosis Fungoides 1Multiple Endocrine Neoplasia Type 2b 1Multiple Endocrine Neoplasia Type 2a 1Multiple Endocrine Neoplasia Type 1 1Melanoma, Cutaneous Malignant 1Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1

Interventions

Temozolomide 2Psychiatric Rehabilitation 2Paclitaxel 2Early Intervention, Educational 2sargramostim 1regorafenib 1pentetreotide 1pembrolizumab 1pazopanib 1imetelstat 1glutathione pegylated liposomal doxorubicin 1durvalumab 1carboxyamido-triazole 1cabozantinib 1binimetinib 1aflibercept 1Trastuzumab 1Thiotepa 1Surveys and Questionnaires 1Radiotherapy 1Quality of Life 1Positron-Emission Tomography 1Pemetrexed 1Patient Reported Outcome Measures 1PF-07284890 1Oxycodone 1Nivolumab 1NEO212 1Morphine 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Temozolomide × Dermatologic × Clear all
NCT00512798 2012-10-02

Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma

Vanderbilt-Ingram Cancer Center

Phase 1/2 Terminated
47 enrolled 9 charts
CNSDermatologic

Brain Neoplasms, Melanoma, Central Nervous System Neoplasms

NCT00629187 2012-04-27

CN-306

Tufts Medical Center

Phase 1 Terminated
2 enrolled
BreastCNSDermatologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Central Nervous System Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡